NCT04733664View on ClinicalTrials.gov

Pilot Study to Evaluate Safety, Tolerability, and Performance of the FAST PV Technology™ in Chronic Dialysis Patients

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

March 9, 2021

Study Completion Date

March 9, 2021

Conditions
End Stage Renal Disease
Interventions
DEVICE

VFI using the FAST PV Technology

The bolus IV administered visible fluorescent injectate (VFI) agent is comprised of a mixture of 2 different molecular weight carboxymethyl dextran molecules (5 kD and 150 kD) with different fluorescent dye molecules attached.

Trial Locations (1)

46202

Richard L. Roudebush VA Medical Center, Indianapolis

Sponsors

Lead Sponsor

FAST BioMedical
All Listed Sponsors
lead

FAST BioMedical

INDUSTRY